Tally Largent-Milnes, PhD, who once aspired to be a physician, has carved out an impactful space in the field of migraine research.

Researchers have found migraine headaches emerge from triggers both inside and outside the brain. UArizona pharmacology professor Dr. Tally Largent Milnes describes the development of new therapies in the works, especially for female patients.

As the national debate continues regarding legalization of marijuana and related products for either medical or recreational use, UArizona researchers examine the research connected to pain management.

UArizona researchers in the Comprehensive Pain and Addiction Center are seeking new therapies for migraine in an unlikely place – the endogenous cannabinoid system.

Researchers at the University of Arizona are studying why women experience pain and addiction differently than men.

Researchers with the UAHS Comprehensive Pain and Addiction Center are working toward closing a 20- to 30-year gap in understanding the link between female hormones, pain and addiction, in an effort to improve the quality of women’s lives.

More than 1.5B people live with chronic pain worldwide, the most common cause of long-term disability in the US, and several BIO5 researchers are addressing the issue tackling the opioid epidemic using basic science and clinical approaches.

UArizona researchers are expanding the scientific knowledge of cannabis with a focus on two distinct areas – pain and addiction, and are optimistic about the potential of cannabis as a viable non-opioid alternative to treat pain.

New grants for UA researchers working on alternative pain medications

The Arizona Biomedical Research Commission has recognized 14 researchers from the UA Health Sciences to receive grant awards totaling more than $5.92 million. Eight of those researchers are BIO5 members.